4.7 Review

Fragile X: Translation in action

Journal

NEUROPSYCHOPHARMACOLOGY
Volume 33, Issue 1, Pages 84-87

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/sj.npp.1301610

Keywords

autism; fragile x; metabotropic glutamate receptor; cerebral protein synthesis; synaptic plasticity; developmental disorder

Funding

  1. NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH067431] Funding Source: NIH RePORTER
  2. NIMH NIH HHS [F30 MH067431] Funding Source: Medline

Ask authors/readers for more resources

Fragile X is a synapsopathy-a disorder of synaptic function and plasticity. Recent studies using mouse models of the disease suggest that the critical defect is altered regulation of synaptic protein synthesis. Various strategies to restore balanced synaptic protein synthesis have been remarkably successful in correcting widely varied mutant phenotypes in mice. Insights gained by the study of synaptic plasticity in animal models of fragile X have suggested novel therapeutic approaches, not only for human fragile X but also for autism and mental retardation of unknown etiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available